OR WAIT null SECS
September 14, 2023
Financial commitment is intended to benefit development and commercialization of new products.
September 13, 2023
Further expansions of the pharmaceutical development and manufacturing services of ten23 are happening at the BASE and VIVA facilities to continue to support complex sterile product development, testing, and manufacturing.
Organization hires Kala Shankle, who joins the team with supply chain security and drug pricing experience.
IATA statistics suggest improvement over recent months.
September 07, 2023
Novo Nordisk receives the full rights to develop and commercialize the lead program.
Pharma Commerce provides a synopsis of the presentation.
September 06, 2023
Biopharma company now required to seek approval before attempting further buyouts.
September 05, 2023
Shift comes with $5 million dedication to launch Cencora’s healthier futures grant program.
Alexion – AstraZeneca Rare Disease, GSK, Novartis, Pfrizer, and Zoetis will join the newly established life sciences platform.
August 29, 2023
Delay to allow agency to consider other ways of solving the issue, filing says.